+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Recent advances in molecular pathogenesis and treatment of polycystic kidney disease



Recent advances in molecular pathogenesis and treatment of polycystic kidney disease



Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 112(1): 11-20



Polycystic kidney diseases (PKD) are common genetic disorders characterized by formation and progressive enlargement of cysts kidney, liver and other organs, leading to end stage renal disease. Regardless of the genetic defect underlying PKD, cystic epithelia seem to display common abnormalities: increased proliferation and apoptosis, loss of cellular differentiation and polarity, hypersecretion. The localization of multiples proteins, whose function are disrupted in PKD, in the primary cilium or at basal body at the base of the cilium highlight this neglected organelle as a common trigger of cystic diseases. Significant progresses have been made over the last few years towards a greater understanding of the molecular pathogenesis of cysts formation, particularly in the signaling pathways involved in cytogenesis: cAMP, mTOR, Wnt, Ras/MAPK. These advances have already brought several potential therapies targeting several key pathways of cystogenesis.

(PDF emailed within 1 workday: $29.90)

Accession: 055398177

Download citation: RISBibTeXText

PMID: 18677899


Related references

Recent advances in molecular pathogenesis and polycystic kidney disease treatment. Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 113(1): 13-22, 2011

Autosomal dominant polycystic kidney disease: recent advances in pathogenesis and treatment. Nephron. Physiology 108(1): P1-P7, 2007

The etiology, pathogenesis, and treatment of autosomal dominant polycystic kidney disease: recent advances. American Journal of Kidney Diseases 28(6): 788-803, 1996

Recent advances in understanding the pathogenesis of polycystic kidney disease: therapeutic implications. Drugs 64(12): 1285-1294, 2004

Autosomal dominant polycystic kidney disease: recent advances in pathogenesis and potential therapies. Clinical and Experimental Nephrology 17(3): 317-326, 2014

Advances in the pathogenesis and treatment of polycystic kidney disease. Current Opinion in Nephrology and Hypertension 18(2): 99-106, 2009

Recent advances in the understanding of polycystic kidney disease. Current Opinion in Nephrology and Hypertension 6(4): 377-383, 1997

Recent advances in the cell biology of polycystic kidney disease. International Review of Cytology 231: 51-89, 2004

Recent advances in autosomal-dominant polycystic kidney disease. Internal Medicine Journal 46(8): 883-892, 2017

Recent advances in the clinical management of autosomal-dominant polycystic kidney disease. Qjm 89(11): 803-806, 1996

Autosomal dominant polycystic kidney disease: recent advances in clinical management. F1000research 5: 2029, 2016

Recent advances in studies on autosomal dominant adult polycystic kidney disease. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 27(4): 402-405, 2010

Pathogenesis of autosomal dominant polycystic kidney disease: recent developments. Contributions to Nephrology 122: 1-9, 1997

Autosomal dominant polycystic kidney disease: Molecular genetics and molecular pathogenesis. Human Genetics 107(2): 115-126, August, 2000